Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone vs Losartan in Mild to Moderate Hypertension
NCT00649311Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Apr 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of eplerenone in hypertension (HTN) (2 arms), sponsored by Pfizer. Primary endpoint: Mean change from baseline in seated trough cuff diastolic blood pressure at 8 weeks. Started Apr 2003; status: terminated.
02
Drugs
eplerenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00649311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00649311.